Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Chemomab Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CMMB.
You can purchase shares of Chemomab Therapeutics (NASDAQ:CMMB) through any online brokerage.
Other companies in Chemomab Therapeutics’s space includes: Aligos Therapeutics (NASDAQ:ALGS), Nanoviricides (AMEX:NNVC), Abpro Hldgs (NASDAQ:ABP), Longeveron (NASDAQ:LGVN) and ABVC BioPharma (NASDAQ:ABVC).
Chemomab Therapeutics has a consensus price target of $8.33.
The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $1.2 last updated April 14, 2025 at 5:11 PM EDT.
There are no upcoming dividends for Chemomab Therapeutics.
Chemomab Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Chemomab Therapeutics.
Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.